Document is current
Any future updates will be listed below
-
Authors
Zou, Zhongyu https://orcid.org/0000-0001-7152-5435
Dou, Xiaoyang
Li, Ying https://orcid.org/0000-0002-3308-906X
Zhang, Zijie https://orcid.org/0000-0002-4900-506X
Wang, Juan
Gao, Boyang https://orcid.org/0000-0002-6956-1450
Xiao, Yu
Wang, Yiding
Zhao, Lijie
Sun, Chenxi https://orcid.org/0009-0000-7849-976X
Liu, Qinzhe
Yu, Xianbin
Wang, Hao
Hong, Juyeong
Dai, Qing https://orcid.org/0000-0002-8578-1568
Yang, Feng-Chun https://orcid.org/0000-0001-8524-4095
Xu, Mingjiang https://orcid.org/0000-0002-7063-6253
He, Chuan https://orcid.org/0000-0003-4319-7424
- License Information
-
More Information
Article History
Received: 25 August 2023
Accepted: 20 August 2024
First Online: 2 October 2024
Change Date: 14 November 2024
Change Type: Update
Change Details: This article was originally published under a CC BY-NC-ND 4.0 license, but has now been made available under a Creative Commons Attribution 4.0 International License.
Competing interests
: The authors have filed a provision patent application of targets reported in this paper through the University of Chicago. C.H. is a scientific founder, a member of the scientific advisory board and equity holder of Aferna Bio and Ellis Bio, a scientific cofounder and equity holder of Accent Therapeutics, and a member of the scientific advisory board of Rona Therapeutics and Element Biosciences. The other authors declare no competing interests.
